Tag Shakeel Modak

Immunotherapy for Neuroblastoma

Acknowledgments We thank Joe Olechnowicz for editorial assistance. Introduction Standard care for patients with high-risk neuroblastoma (NB) currently consists of aggressive multimodal therapy including high-dose chemotherapy, surgery, and radiotherapy . Immunotherapy utilizes mechanisms of action that are not cross-reactive with…